| 1 | biofactura develops and manufactures | | | | | | | 2 | 0.86% |
| 2 | biofacturabiofactura company management board | | | | | | | 1 | 0.43% |
| 3 | today announced a contract | | | | | | | 1 | 0.43% |
| 4 | its smallpox biodefense therapeutic | | | | | | | 1 | 0.43% |
| 5 | smallpox biodefense therapeutic frederick | | | | | | | 1 | 0.43% |
| 6 | biodefense therapeutic frederick maryland | | | | | | | 1 | 0.43% |
| 7 | therapeutic frederick maryland october | | | | | | | 1 | 0.43% |
| 8 | frederick maryland october 2 | | | | | | | 1 | 0.43% |
| 9 | 2023 biofactura inc today | | | | | | | 1 | 0.43% |
| 10 | biofactura inc today announced | | | | | | | 1 | 0.43% |
| 11 | inc today announced a | | | | | | | 1 | 0.43% |
| 12 | announced a contract option | | | | | | | 1 | 0.43% |
| 13 | 16 million contract option | | | | | | | 1 | 0.43% |
| 14 | a contract option activation | | | | | | | 1 | 0.43% |
| 15 | 11sep biofactura publishes phase | | | | | | | 1 | 0.43% |
| 16 | biofactura publishes phase 1 | | | | | | | 1 | 0.43% |
| 17 | publishes phase 1 data | | | | | | | 1 | 0.43% |
| 18 | phase 1 data on | | | | | | | 1 | 0.43% |
| 19 | 1 data on its | | | | | | | 1 | 0.43% |
| 20 | data on its ustekinumab | | | | | | | 1 | 0.43% |
| 21 | on its ustekinumab biosimilar | | | | | | | 1 | 0.43% |
| 22 | million contract option for | | | | | | | 1 | 0.43% |
| 23 | funded 16 million contract | | | | | | | 1 | 0.43% |
| 24 | maryland september 11 2023 biofactura | | | | | | | 1 | 0.43% |
| 25 | more 75grantscontracts awarded 2 | | | | | | | 1 | 0.43% |
| 26 | and manufacturing read more | | | | | | | 1 | 0.43% |
| 27 | manufacturing read more numbers | | | | | | | 1 | 0.43% |
| 28 | read more numbers dont | | | | | | | 1 | 0.43% |
| 29 | liewhat makes us special? | | | | | | | 1 | 0.43% |
| 30 | clientselected novel drugs learn | | | | | | | 1 | 0.43% |
| 31 | novel drugs learn more | | | | | | | 1 | 0.43% |
| 32 | drugs learn more 75grantscontracts | | | | | | | 1 | 0.43% |
| 33 | learn more 75grantscontracts awarded | | | | | | | 1 | 0.43% |
| 34 | better yields 24target pipeline | | | | | | | 1 | 0.43% |
| 35 | biofactura funded 16 million | | | | | | | 1 | 0.43% |
| 36 | company management board of | | | | | | | 1 | 0.43% |
| 37 | 24target pipeline market 3 | | | | | | | 1 | 0.43% |
| 38 | pipeline market 3 faster | | | | | | | 1 | 0.43% |
| 39 | market 3 faster to | | | | | | | 1 | 0.43% |
| 40 | 3 faster to production | | | | | | | 1 | 0.43% |